Redirecting you to external site in 3 seconds : https://www.globenewswire.com/news-release/2024/02/15/2830145/0/en/OrphAI-Therapeutics-receives-Orphan-Drug-Designation-for-AIT-101-as-a-treatment-for-amyotrophic-lateral-sclerosis-in-the-European-Union.html
If you are not automatically redirected, please